Skip to content
BEAM·Nasdaq·US

Beam Therapeutics

Beam Therapeutics is a biotechnology company focused on precision genetic medicines built around base editing and related gene-editing technologies. It has no meaningful product sales revenue and has instead generated revenue primarily from collaboration, license, and partner payments.

Thematic Position

BEAM

Relationship Groups

Suppliers1
Partners4
Licensing5
Competitors20

Relationship details are part of the Pro plan.

Recent Discoveries

Recent discoveries are part of the Pro plan.

Ended Relationships

6 ended relationships · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

state aiddrug pricing regulation
Inflation Reduction Act Medicare pricing and rebate provisions affecting drug pricing
SEC 10-KFeb 24, 2026

The full regulatory passage is part of the Pro plan.

8 more · Regulatory and geopolitical insights are part of the Pro plan.